Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E T Creagan

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Cancer|April 1, 1996
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinomaJ T Schleusener, H D Tazelaar, S H Jung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcomaJ H Edmonson, S J Green, J C Ivins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapyV Liengswangwong, J A Bonner, E G Shaw, et al.
American Journal of Clinical Oncology|April 1, 1996
Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lungE G Shaw, S Frytak, R T Eagan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1989
Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lungJ S Robinow, E G Shaw, R T Eagan, et al.
American Journal of Clinical Oncology|April 16, 1998
Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: a phase II studyE T Creagan, R D Hestorff, V J Suman, et al.
Cancer|March 20, 1998
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III StudyJ A Bonner, W L McGinnis, P J Stella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanomaE T Creagan, V J Suman, R J Dalton, et al.
American Journal of Clinical Oncology|October 22, 1998
A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinomaE T Creagan, M H Veeder, V J Suman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 1991
A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinomaE T Creagan, D I Twito, S L Johansson, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Cancer|April 1, 1996
Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinomaJ T Schleusener, H D Tazelaar, S H Jung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcomaJ H Edmonson, S J Green, J C Ivins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapyV Liengswangwong, J A Bonner, E G Shaw, et al.
American Journal of Clinical Oncology|April 1, 1996
Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lungE G Shaw, S Frytak, R T Eagan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1989
Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lungJ S Robinow, E G Shaw, R T Eagan, et al.
American Journal of Clinical Oncology|April 16, 1998
Combined levamisole with recombinant interleukin-2 (IL-2) in patients with advanced renal cell carcinoma: a phase II studyE T Creagan, R D Hestorff, V J Suman, et al.
Cancer|March 20, 1998
The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III StudyJ A Bonner, W L McGinnis, P J Stella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced malignant melanomaE T Creagan, V J Suman, R J Dalton, et al.
American Journal of Clinical Oncology|October 22, 1998
A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinomaE T Creagan, M H Veeder, V J Suman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 1991
A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinomaE T Creagan, D I Twito, S L Johansson, et al.
Pageof 12